(Q40380303)

20 September 2017

Evidence for p62 aggregate formation: role in cell survival (English)

1 reference

20 September 2017

Michael G Paine

1

1 reference

20 September 2017

J Ramesh Babu

series ordinal

2

1 reference

20 September 2017

M Lamar Seibenhener

series ordinal

3

1 reference

20 September 2017

Marie W Wooten

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

20 September 2017

1 reference

20 September 2017

579

1 reference

20 September 2017

5029-5034

1 reference

20 September 2017

22

1 reference

Structure and functional properties of the ubiquitin binding protein p62

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Rings, chains and ladders: ubiquitin goes to work in the neuron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Localization to the proteasome is sufficient for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Aggresomes, inclusion bodies and protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Hassles with taking out the garbage: aggravating aggresomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Neurological disease: UPS stops delivering!

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

p62 is involved in the mechanism of Mallory body formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.08.010

10.1016/J.FEBSLET.2005.08.010

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference